1. Home
  2. SLNG vs CNTX Comparison

SLNG vs CNTX Comparison

Compare SLNG & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$5.08

Market Cap

92.0M

Sector

Utilities

ML Signal

N/A

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
CNTX
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
102.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SLNG
CNTX
Price
$5.08
$1.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$10.00
$5.40
AVG Volume (30 Days)
5.6K
507.0K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$72,270,000.00
N/A
Revenue This Year
$7.02
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
$93.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.29
$0.49
52 Week High
$8.28
$1.55

Technical Indicators

Market Signals
Indicator
SLNG
CNTX
Relative Strength Index (RSI) 62.76 54.28
Support Level $4.92 $0.99
Resistance Level $5.17 $1.10
Average True Range (ATR) 0.15 0.08
MACD 0.03 0.00
Stochastic Oscillator 96.97 78.39

Price Performance

Historical Comparison
SLNG
CNTX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: